CPD-Accredited Webinar | Emerging Biomarkers in Spinal Muscular Atrophy
NMD4C are MDC are pleased to invite you to a CPD-accredited webinar on Emerging biomarkers in spinal muscular atrophy. This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular diseases. NMD4C and MDC are providing organizational and technical support. This is an independent clinical/academic webinar with no industry sponsorship or influence.
Speakers:
- Hugh McMillan MD, MSc, FRCPC (Chair)
- Charlotte René, PhD
Details:
- Date: Tuesday, June 16, 2026
- Time: 5-6 pm ET
Learning Objectives:
- Define biomarkers and their relation to SMA
- Discuss genetic modifiers above & beyond SMN2 copy number
- Review the role of neurofilament
- Discuss the role of extracellular vesicles and their role in SMA.
The NMD Rounds & Educational Webinars are self-approved group learning activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
If you have any questions, please contact our Network Manger, Erin Beattie.


